PCSA Processa Pharmaceuticals posts worsethanexpected Q4 2025 EPS results that miss estimates by 68 percent as shares edge 033 percent lower NCS NCSM Stock diluted Shares Investor Interest 20260427 Bank of America Corporation BAC Bullish Case Strengthens Post Q1 2026 Earnings Beat Outperforms Peer American Express in NearTerm Value